The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index, and 1 are not checked yet.
Catechol O -methyltransferase val 158 -met genotype and individual variation in the brain response to amphetamine
Open accessAbstract
Monamines subserve many critical roles in the brain, and monoaminergic drugs such as amphetamine have a long history in the treatment of neuropsychiatric disorders and also as a substance of abuse. The clinical effects of amphetamine are quite variable, from positive effects on mood and cognition in some individuals, to negative responses in others, perhaps related to individual variations in monaminergic function and monoamine system genes. We explored the effect of a functional polymorphism ( val 158 -met ) in the catechol O -methyltransferase gene, which has been shown to modulate prefrontal dopamine in animals and prefrontal cortical function in humans, on the modulatory actions of amphetamine on the prefrontal cortex. Amphetamine enhanced the efficiency of prefrontal cortex function assayed with functional MRI during a working memory task in subjects with the high enzyme activity val / val genotype, who presumably have relatively less prefrontal synaptic dopamine, at all levels of task difficulty. In contrast, in subjects with the low activity met / met genotype who tend to have superior baseline prefrontal function, the drug had no effect on cortical efficiency at low-to-moderate working memory load and caused deterioration at high working memory load. These data illustrate an application of functional neuroimaging in pharmacogenomics and extend basic evidence of an inverted-“U” functional-response curve to increasing dopamine signaling in the prefrontal cortex. Further, individuals with the met / met catechol O -methyltransferase genotype appear to be at increased risk for an adverse response to amphetamine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have shown that WM performance in psychotic and healthy subjects rely on dopamine levels within the PFC (Dumontheil et al., 2011; Mattay et al., 2003; Okubo et al., 1997).”
From Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits (2023) · cites this paper as Mattay et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“some human participants who had lower baseline dopamine levels (due to Val/Val allele in COMT gene), showed improved WM performance after dexamphetamine administration, while others who had a higher dopamine level (met/met allele subjects) showed the opposite effect”
From Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits (2023) · cites this paper as Mattay et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, methionine substitutions in COMT increase the stress response in mice75 and make humans more susceptible to cognitive impairment following stress and psychostimulant medication74.”
From Stress signalling pathways that impair prefrontal cortex structure and function (2009) · cites this paper as [74]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the methionine substitution in the COMT protein that results from one of the COMT polymorphisms reduces the ability of COMT to catabolize dopamine and increases vulnerability to stress- or stimulant-induced working memory impairments in human subjects74 and in mice75.”
From Stress signalling pathways that impair prefrontal cortex structure and function (2009) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurophysiological investigation of the basis of the fMRI signal
Logothetis, N. K., Pauls, J., Augath, M., Trinath, T., & Oeltermann, A. (2001) · Nature · doi:10.1038/35084005 · Cited by 6,551
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D. A., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,416
Self-citationModulation of memory fields by dopamine Dl receptors in prefrontal cortex
Williams, G. V., & Goldman-Rakic, P. S. (1995) · Nature · doi:10.1038/376572a0 · Cited by 1,593
Allelic discrimination using fluorogenic probes and the 5' nuclease assay.
Livak, K. (1999) · Genetic Analysis, Techniques and Applications (GATA) · doi:10.1016/s1050-3862(98)00019-9 · Cited by 1,352
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
Pierce, R. C., & Kalivas, P. W. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00021-0 · Cited by 1,239
Männistö, P. T., & Kaakkola, S. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01423-6 · Cited by 1,068
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916
Gogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., & Karayiorgou, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9991 · Cited by 864
Allelic discrimination using fluorogenic probes and the 5' nuclease assay
Foitzi, T. (1999) · Medical Entomology and Zoology · Cited by 783
Callicott, J. H. (1999) · Cerebral Cortex · doi:10.1093/cercor/9.1.20 · Cited by 771
Self-citation
Research works printed but not linked: 1
- P Mannisto, S Kaakkola Pharmacol Rev 51, 593–628 (1999).
Cited by
Sorted by citations
Items 701–800 of 893
Wu, S., Upadhyay, N., Lu, J., Jiang, X., Li, S., Zhao, Q., Wang, J., Liang, X., Zhang, X., & Zhang, B. (2020) · Brain and Behavior · doi:10.1002/brb3.1784 · Cited by 6
5-HT6 Receptors as Targets for the Treatment of Cognitive Deficits in Schizophrenia
Schreiber, R., Sleight, A. J., & Woolley, M. L. (2006) · The Receptors · doi:10.1007/978-1-59745-080-5_17 · Cited by 7
Experimental Psychology and Research into Brain Science, Addiction and Drugs
Duka, T., Sahakian, B. J., & Turner, D. C. (2007) · Elsevier eBooks · doi:10.1016/b978-012370624-9/50008-6 · Cited by 7
Fluid Cognitive Abilities and General Intelligence
Blair, C. (2010) · Wiley eBooks · doi:10.1002/9780470880166.hlsd001008 · Cited by 7
Gong, J., Zhang, T., Zhou, L., Mo, Y., Yu, F., Liu, M., Yang, L., & Liu, J. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114215 · Cited by 8
Développement intellectuel au cours du cycle de vie : sources de variabilité et niveaux d’analys
Lindenberger, U., & Chicherio, C. (2008) · L’Année psychologique · doi:10.4074/s0003503308004077 · Cited by 6
Reduced brain activation during inhibitory control in children with COMT Val/Val genotype
Cope, L. M., Hardee, J. E., Soules, M. E., Burmeister, M., Zucker, R. A., & Heitzeg, M. M. (2016) · Brain and Behavior · doi:10.1002/brb3.577 · Cited by 6
Carrà, G., Nicolini, G., Crocamo, C., Lax, A., Amidani, F., Bartoli, F., Castellano, F., Chiorazzi, A., Gamba, G., Papagno, C., et al. (2017) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2017.1286385 · Cited by 6
Tang, J., Li, Y., Xu, J., Qin, W., Su, Q., Xu, Q., Liu, B., Jiang, T., & Yu, C. (2019) · Brain Structure and Function · doi:10.1007/s00429-019-01924-7 · Cited by 6
Imaging Genetics and Psychiatry
Kempf, L., & Meyer‐Lindenberg, A. (2006) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.4.3.327 · Cited by 6
Kempton, M. J., Haldane, M., Jogar, J., Christodoulou, T., Powell, J. F., Collier, D. A., Williams, S., & Frangou, S. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2008.01.1035 · Cited by 6
Autism Spectrum Disorders: An Intervention Approach Based on Genomic Analysis
Lao, J. I. (2014) · Biology and Medicine · doi:10.4172/0974-8369.s1-002 · Cited by 6
Genetic Associations in Schizophrenia
O’Donovan, M. C., & Owen, M. J. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch13 · Cited by 6
Asherson, P. J., & Price, T. S. (2012) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2012.02534.x · Cited by 6
Neuroenhancement: State of the Art and Future Perspectives.
Marazziti, D., Avella, M. T., Ivaldi, T., Palermo, S., Massa, L., Vecchia, A. D., Basile, L., & Mucci, F. (2021) · PubMed Central · doi:10.36131/cnfioritieditore20210303 · Cited by 6
Kumar, P., Harmer, C. J., & Dourish, C. T. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-386945-6.00012-3 · Cited by 6
Current Genetic Discoveries and Education: Strengths, Opportunities, and Limitations
Bates, T. C. (2008) · Mind Brain and Education · doi:10.1111/j.1751-228x.2008.00035.x · Cited by 5
Lamb, Y. N., McKay, N. S., Singh, S. S., Waldie, K. E., & Kirk, I. J. (2016) · Frontiers in Psychology · doi:10.3389/fpsyg.2016.00965 · Cited by 5
Neuroimaging of sleep disorders
Nofzinger, E. A., Maquet, P., & Thorpy, M. J. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139088268.025 · Cited by 5
Catechol-O-methyltransferase gene expression in stress-induced and non-stress induced schizophrenia
Aghamaleki-Sarvestani, Z., Vousooghi, N., Tabrizi, M. H., Alipour, M., Alaghband‐Rad, J., Abdolmaleky, H. M., & Zarindast, M. R. (2019) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000243 · Cited by 5
Correlations between COMT polymorphism and brain structure and cognition in elderly subjects
Cha, E., Ahn, H. J., Kang, W., Jung, K., Ohn, S. H., Bashir, S., & Yoo, W. (2022) · Medicine · doi:10.1097/md.0000000000029214 · Cited by 5
The behavioral effects of chronic sugar and/or caffeine consumption in adult and adolescent rats.
Franklin, J. L., Wearne, T. A., Homewood, J., & Cornish, J. L. (2017) · Behavioral Neuroscience · doi:10.1037/bne0000204 · Cited by 6
Pharmacogenomics and Psychiatric Clinical Care
Amato, R. J., Boland, J. R., Myer, N. M., Few, L. R., & Dowd, D. (2017) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20170928-01 · Cited by 5
Park, S., Kim, J.-W., Kim, B.-N., Shin, M., Yoo, H., & Cho, S.-C. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114527654 · Cited by 5
Cognitive Dysfunction in Schizophrenia: A Perspective from the Clinic to Genetic Brain Mechanisms
Tan, H. Y. (2009) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v38n5p420 · Cited by 5
The Neurochemical Modulation of Prefrontal Control Processes
Robbins, T. W., & Kehagia, A. A. (2017) · The Wiley Handbook of Cognitive Control · doi:10.1002/9781118920497.ch19 · Cited by 4
A neurological perspective on the enhancement debate: Lessons learned from Parkinson’s disease
Kehagia, A. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116665328 · Cited by 3
Fan, J., Yang, C., Liu, Z., He, L., Han, Y., Chen, K., Chen, C., Wang, J., & Zhang, Z. (2020) · Aging · doi:10.18632/aging.104059 · Cited by 4
The effects of caffeine and d-amphetamine on spatial span task in healthy participants
Kassim, F. M., Lim, J. H. M., Slawik, S. V., Gaus, K., Peters, B., Lee, J. W. Y., Hepple, E. K., Rodger, J., Albrecht, M. A., & Martin-Iverson, M. T. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287538 · Cited by 7
Recław, R., Chmielowiec, K., Suchanecka, A., Boroń, A., Chmielowiec, J., Strońska-Pluta, A., Kowalski, M. T., Masiak, J., Trybek, G., & Grzywacz, A. (2024) · Genes · doi:10.3390/genes15030299 · Cited by 4
Pre-attentive operation and psychoticism: A P50 event related potential study
Papageorgiou, C., Beratis, I., Rabavilas, A., Nanou, E. D., Chountala, C., Maganioti, A. E., Capsalis, C., Papadimitriou, G., & Stefanis, C. (2010) · Personality and Individual Differences · doi:10.1016/j.paid.2010.05.025 · Cited by 4
Vagal nerve stimulation for refractory epilepsy: a brief review
Mehranfard, N., & Sarkaki, A. (2016) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000134 · Cited by 4
Mental Function as Genetic Expression: Emerging Insights From Cognitive Neurogenetics
Green, A. E., & Dunbar, K. N. (2012) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780199734689.013.0007 · Cited by 5
Challenges Associated With Neuropharmacological Challenge Studies
Mathalon, D. H. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.08.015 · Cited by 4
Gründer, G., & Bartsch, T. (2014) · Der Nervenarzt · doi:10.1007/s00115-013-3977-3 · Cited by 6
Schizophrénie et/ou trouble bipolaire : les endophénotypes neurobiologiques
Adida, M., Azorin, J., Fakra, É., Belzeaux-R, R., Kaladjian, A., Mazzola‐Pomietto, P., & Correard, N. (2012) · L Encéphale · doi:10.1016/s0013-7006(12)70086-6 · Cited by 4
Cools, R., Aarts, E., & Mehta, M. A. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511978098.025 · Cited by 4
Endophenotypes in psychiatric genetics
Chen, A. C. H., Rangaswamy, M., & Porjesz, B. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139025997.030 · Cited by 4
Leventhal, A. M., Kirkpatrick, M. G., Pester, M. S., McGeary, J. E., Swift, R. M., Sussman, S. Y., & Kahler, C. W. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4462-z · Cited by 4
Fuster, J. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-407815-4.00003-9 · Cited by 4
The Diagnostic and Therapeutic Potential of Neuroimaging in Addiction Medicine
Reske, M., & Paulus, M. P. (2011) · Wiley eBooks · doi:10.1002/9781119998938.ch13 · Cited by 4
Hemmings, S. M. J. (2006) · SUNScholar (Stellenbosch University) · Cited by 4
Zhang, X., Yan, H., Yu, H., Zhao, X., Shah, S., Dong, Z., Yang, G., Zhang, X., Muse, T., Li, J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/246876 · Cited by 4
Self-citationCognitive enhancers versus stimulants
Peters, M. A. K., & Sarter, M. F. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511783005.012 · Cited by 2
Stimulants: Abuse and Performance Enhancement (or Lack Thereof)
Namdari, B., & Kollins, S. H. (2015) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.130302 · Cited by 3
López-García, P., Young, L., Marín, J., Molero, P., & Ortuño, F. (2015) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2015.10.002 · Cited by 3
El‐Hage, W., Cléry, H., Andersson, F., Filipiak, I., de Schotten, M. T., Gohier, B., & Surguladze, S. (2017) · Brain and Behavior · doi:10.1002/brb3.786 · Cited by 3
Genetic, Epigenetic, and Transcriptomic Studies of NeuroAIDS
Levine, A. J., Singh, K. K., & Kallianpur, A. R. (2017) · Springer eBooks · doi:10.1007/978-1-4939-7290-6_19 · Cited by 3
Apa, Z. L., Gilsoul, J., Dideberg, V., & Collette, F. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303343 · Cited by 3
Diekhof, E. K., Geana, A., Ohm, F., Doll, B. B., & Frank, M. J. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.658769 · Cited by 3
Context, goals, and behavioral regulation in schizophrenia: Psychological and neural mechanisms.
Barch, D. M., & Braver, T. S. (2009) · American Psychological Association eBooks · doi:10.1037/11884-002 · Cited by 3
Leadership Style, Headache, and Neck Pain
Christensen, J. O., Nielsen, M. B., Sannes, A., & Gjerstad, J. (2020) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000002103 · Cited by 4
Plichta, M. M. (2009) · Online Publication Service of Würzburg University (Würzburg University) · Cited by 3
Colzato, L. S., & Arntz, F. E. (2017) · Theory-Driven Approaches to Cognitive Enhancement · doi:10.1007/978-3-319-57505-6_6 · Cited by 2
Kalak, M., Brylak-Błaszków, A., Błaszków, Ł., & Kalak, T. (2025) · Genes · doi:10.3390/genes16121487 · Cited by 2
IMAGING BIOMARKERS IN DRUG DEVELOPMENT: CASE STUDIES
Tauscher, J. T., & Schwarz, A. J. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511976087.012 · Cited by 2
Dynamics of a Neuromodulator – II. Dopaminergic Balance and Cognition
Aboitiz, F. (2008) · Springer eBooks · doi:10.1007/978-3-540-70573-4_11 · Cited by 2
Noninvasive Brain Imaging for Experimental Medicine in Drug Discovery and Development
Whitcher, B. J., & Matthews, P. M. (2006) · International Journal of Pharmaceutical Medicine · doi:10.2165/00124363-200620030-00003 · Cited by 2
The Effect of Regular Exercise on Cognition in Special Populations of Children
Bustamante, E. E., Krafft, C. E., Schaeffer, D. J., McDowell, J. E., & Davis, C. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800778-5.00021-9 · Cited by 2
Dahmardeh, F., & Rezaeifar, A. (2019) · Gene Cell and Tissue · doi:10.5812/gct.91912 · Cited by 3
Environment and genetic predictors of infant attachment disorganization
Gedaly, L. R. (2015) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro) · Cited by 2
Attention-deficit hyperactivity disorder
Elia, J., Lantieri, F., Takeda, T., Gai, X., White, P. S., Devoto, M., & Hakonarson, H. H. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139025997.016 · Cited by 2
10.4 Dopamine Dysfunction in Schizophrenia: From Genetic Susceptibility to Cognitive Impairment
Tost, H., Hakimi, S., & Meyer‐Lindenberg, A. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195373035.003.0039 · Cited by 2
Billino, J., Hennig, J., & Gegenfurtner, K. R. (2016) · Vision Research · doi:10.1016/j.visres.2016.10.001 · Cited by 2
White, T. L., Gonsalves, M. A., Zimmerman, C. S., Joyce, H., Cohen, R. A., Clark, U. S., Sweet, L. H., Lejuez, C. W., & Nitenson, A. Z. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1060877 · Cited by 2
Winterer, G. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9464-4_4 · Cited by 2
Amitai, N., Powell, S. B., Weber, M., Swerdlow, N. R., & Young, J. W. (2015) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-015-0369-0 · Cited by 2
Chapter 6.1 The role of microdialysis in drug discovery: focus on antipsychotic agents
Millan, M. J., Panayi, F., Rivet, J., Cara, B. D., Cistarelli, L., Billiras, R., Girardon, S., & Gobert, A. (2006) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(06)16026-9 · Cited by 2
Imaging Genetics: Unraveling the Neurogenetic Risk Architecture of Mental Illness
Tost, H., Böhringer, A., & Meyer‐Lindenberg, A. (2014) · Springer eBooks · doi:10.1007/978-3-642-54542-9_7 · Cited by 2
Psychiatric Neuroscience: Incorporating Pathophysiology into Clinical Case Formulation
Morrow, E. M., Roffman, J. L., Wolf, D. H., & Coyle, J. T. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04743-2.50042-1 · Cited by 2
Fuster, J. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373644-4.00003-7 · Cited by 2
Elfferich, A. (2021) · Canadian Journal of Bioethics · doi:10.7202/1077629ar · Cited by 2
New insights on attention‐deficit/hyperactivity disorder pharmacogenomics
Rohde, L. A., Zeni, C., Polanczyk, G. V., & Hutz, M. H. (2004) · Drug Development Research · doi:10.1002/ddr.10380 · Cited by 2
Zokaei, N. (2013) · UCL Discovery (University College London) · Cited by 2
Von der Grundlagenforschung zum klinischen Einsatz in Diagnostik und Therapie
Fink, G. R., & Schneider, F. W. (2007) · Springer eBooks · doi:10.1007/978-3-540-68558-6_46 · Cited by 1
COMT, DRD1, DRD2, DRD4: Genetic evidence for the dopamine hypothesis in schizophrenia
Dong, D. (2022) · AIP conference proceedings · doi:10.1063/5.0112965 · Cited by 1
Oelschlegel, A. M., Pöpplau, J. A., Ryzynski, A., Hradsky, J., Reddy, P. P., Navarro, G., Reyes‐Resina, I., Yuanxiang, P., Sosulina, L., Kaneko, H., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.10.038 · Cited by 1
Stimulant Reversal of Cognitive Deficits
Wesensten, N. J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511783005.007 · Cited by 1
Pharmacogenomics of Attention-Deficit/Hyperactivity Disorder
Froehlich, T. E., & Stein, M. A. (2010) · Advances in biological psychiatry · doi:10.1159/000317300 · Cited by 1
Li, S. (2010) · American Psychological Association eBooks · doi:10.1037/12140-002 · Cited by 1
(2015) · Neurotransmitter · doi:10.14800/nt.483 · Cited by 1
Molecular Genetics of Brain Noradrenergic Neurotransmission
Meloni, R. (2008) · Springer eBooks · doi:10.1007/978-0-387-30382-6_6 · Cited by 1
Managò, F., Huang, H., & Papaleo, F. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00006-7 · Cited by 1
Tan, H. Y., & Weinberger, D. R. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195373035.003.0013 · Cited by 1
Self-citationGoldman, D. A., Búzás, B., & Xu, K. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511757402.028 · Cited by 1
Lazzaretti, M., Mandolini, G. M., Altamura, A. C., & Brambilla, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-75124-5_1 · Cited by 1
Translational Medicine in Psychiatry
Meyer‐Lindenberg, A., Tost, H., & Schwarz, E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800687-0.00021-9 · Cited by 1
Translational medicine in psychiatry: challenges and imaging biomarkers
Meyer‐Lindenberg, A., Tost, H., & Schwarz, E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820493-1.00004-0 · Cited by 1
Neuropharmakologische funktionelle Bildgebung
Thiel, C. M., & Fink, G. R. (2013) · Springer eBooks · doi:10.1007/978-3-642-29800-4_12 · Cited by 1
Gründer, G. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_61 · Cited by 1
Goldman, D. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-22161-3.00006-5 · Cited by 1
López-García, P., Young, L., Marín, J., Molero, P., & Ortuño, F. (2015) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2015.05.004 · Cited by 1
Neuroimaging Biomarkers in Schizophrenia
Tost, H., & Meyer‐Lindenberg, A. (2008) · Springer eBooks · doi:10.1007/978-0-387-79251-4_11 · Cited by 1
From Treating Mental Dysfunction to Neuroenhancement
Koch, M. (2013) · Happiness studies book series · doi:10.1007/978-94-007-6609-9_8 · Cited by 1
COMPT (CATHECOL O METHYL TRANSFERASE) GENE AS GENETIC RISK FACTOR FOR JAVANESE SCHIZOPHRENIA
Sutrisna, E., & Yuliani, R. (2016) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 1
New drug targets in psychiatry: Neurobiological considerations in the genomics era
Harrison, P. J., Mould, A. W., & Tunbridge, E. M. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104763 · Cited by 1
Die Neurobiologie der Depression - im Fokus: Imaging Genetics
Pezawas, L., Moser, U., & Kasper, S. F. (2007) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1
Imaging Genetics and Addiction
Srivastava, V., & Goldman, D. A. (2011) · Wiley eBooks · doi:10.1002/9781119998938.ch12 · Cited by 1
Tammimäki, A. (2008) · Työväentutkimus Vuosikirja · Cited by 1
Using neuroimaging to measure drug responses
Mehta, M. A., & Richell, R. A. (2005) · Psychiatry · doi:10.1383/psyt.2005.4.12.10 · Cited by 1
Metadata
- Authors
- Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., & Weinberger, D. R.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-04-25
- Volume
- 100
- Issue
- 10
- Pages
- 6186-6191
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC156347
- OpenAlex
- W2123636362
- Cited by
- 893
- References
- 36
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 8 · 2023: 8 · 2022: 9 · 2021: 10 · 2020: 19 · 2019: 13 · 2018: 17 · 2017: 30 · 2016: 34 · 2015: 51 · 2014: 50 · 2013: 66 · 2012: 61
- FWCI
- 19.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- National Institute of Mental Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- catechol-O-methyltransferase, COMT Val158Met polymorphism, amphetamine, prefrontal cortex, working memory, dopamine signaling, pharmacogenomics, individual differences, monoaminergic systems
- MeSH terms
- Brain, Catechol O-Methyltransferase, Dextroamphetamine, DNA, Genotype, Humans, Magnetic Resonance Imaging, Methionine, Organ Specificity, Valine, Amino Acid Substitution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
